In memoriam of Alain Cribier https://t.co/bIDsM5HGTG
It was with deep sadness that PCR and the interventional community learnt today of the sudden passing of Alain Cribier.
Professor Cribier changed the face of cardiology forever by creating the transcatheter aortic valve #TAVI, but above all he was a true gentleman, a kind-hearted and generous person, who endeared himself to his colleagues and cared deeply about his patients.
Our most sincere and heartfelt condolences to Alain Cribier's family, colleagues and loved ones - may he rest in peace.
@heleltchaninoff@EAPCIPresident
📣 Aufstehen, rausgehen: am 5.2.24!
Frankfurt/Rhein-Main lebt von Weltoffenheit & Vielfalt. Deshalb rufen wir als Goethe-Uni gemeinsam mit einem breiten Bündnis dazu auf, Gesicht zu zeigen für unsere offene Gesellschaft. Lasst uns gemeinsam ein Zeichen setzen: #NieWiederIstJetzt
The first coronary angioplasty was performed by Andreas Grüntzig on 16 September 1977
A UN resolution in 2022 has declared this day henceforth as the International Day for Interventional Cardiology to raise awareness of CVD & procedures as well as prevention and care. It notes that interventional cardio-angiology improves health, increases life expectancy and improves QoL, and the importance of angioplasty as a life-saving procedure.
Happy #InterventionalCardiology Day 2023!
Read article ✍️🏼 by @NievesGonzalo1
https://t.co/P84biy8U9l
CAMINAR DISMINUYE EL RIESGO DE MUERTE Y EVENTOS 🫀
Metanálisis 12 estudios. >111300 👥
Comparado con 2000 pasos/d:
-2517-2738 pasos/d ⬇️riesgo muerte total y enfermedad CV
-A mayor num. pasos ⏩️ mayor el beneficio
Vía @JACCJournals
https://t.co/EM5jfnbhvE
CAMINAR DISMINUYE EL RIESGO DE MUERTE Y EVENTOS 🫀
Metanálisis 12 estudios. >111300 👥
Comparado con 2000 pasos/d:
-2517-2738 pasos/d ⬇️riesgo muerte total y enfermedad CV
-A mayor num. pasos ⏩️ mayor el beneficio
Vía @JACCJournals
https://t.co/EM5jfnbhvE
Eugene Braunwald at #ESCCongress in a great conversation about HCM on the ESC TV stage with @charles_driving , emphasizing that in HOCM, septal reduction should be considered if and only if symptoms remain under med therapy (including mevacamten if available)
@escardio
Late breaking at #ESCCongress:
In a trial involving older patients with myocardial infarction and multivessel disease, physiology-guided complete revascularization led to a lower risk of cardiac events than culprit-only PCI.
Full results of the FIRE trial:
Presented at #ESCCongress:
In this randomized trial, extracorporeal life support did not improve 30-day survival as compared with usual care in patients with acute myocardial infarction complicated by cardiogenic shock.
Full ECLS-SHOCK trial results: https://t.co/gsxcdgQpg9
Incredibly proud and grateful!
Results of #ECLSSHOCK trial and corresponding IPD-Metaanalysis just presented at #ESCCongress@thiele_holger
and simultaneously published
https://t.co/r0K5dND6xT
https://t.co/LBvhcr02aY
▶️ No benefit of early unselective #ECLS in #AMICS ◀️